Chih-ying Hsieh

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.

ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.

Journal: American journal of cancer research
Published: February 11, 2024

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy.

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy.

Journal: Nature cancer
Published: December 04, 2022

Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment.

Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment.

Journal: Molecular oncology
Published: August 25, 2022

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma.

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma.

Journal: International journal of biological sciences
Published: July 29, 2021

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.

Journal: Theranostics
Published: September 12, 2020

Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy.

Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy.

Journal: American journal of cancer research
Published: January 30, 2020

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis.

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis.

Journal: Scientific reports
Published: January 15, 2019

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.

Journal: Scientific reports
Published: February 17, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026